Product NDC: | 0310-0115 |
Proprietary Name: | TENORETIC |
Non Proprietary Name: | Atenolol and Chlorthalidone |
Active Ingredient(s): | 50; 25 mg/1; mg/1 & nbsp; Atenolol and Chlorthalidone |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0310-0115 |
Labeler Name: | AstraZeneca Pharmaceuticals LP |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018760 |
Marketing Category: | NDA |
Start Marketing Date: | 19900901 |
Package NDC: | 0310-0115-10 |
Package Description: | 100 TABLET in 1 BOTTLE (0310-0115-10) |
NDC Code | 0310-0115-10 |
Proprietary Name | TENORETIC |
Package Description | 100 TABLET in 1 BOTTLE (0310-0115-10) |
Product NDC | 0310-0115 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Atenolol and Chlorthalidone |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19900901 |
Marketing Category Name | NDA |
Labeler Name | AstraZeneca Pharmaceuticals LP |
Substance Name | ATENOLOL; CHLORTHALIDONE |
Strength Number | 50; 25 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Increased Diuresis [PE],Thiazide-like Diuretic [EPC] |